IRBESARTAN IN THE CLINICAL PRACTICE

IRBESARTAN IN THE CLINICAL PRACTICE

Show other versions (1)

<p>Only few hypertensive patients are treated effectively despite of the variety of antihypertensive drugs. There is a linear relationship between blood pressure levels and the risk of complications (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers...

Full description

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. I. Tarzimanova
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	ирбесартан блокаторы рецепторов к ангиотензину артериальная гипертензия нефропротективный эффект
Online Access:	http://www.rpcardio.ru/jour/article/view/306

Similar Items

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?
by: M V Shestakova
Published: (2005-03-01)

Angiotensin II receptor blockers and cardiorenal risk management: Irbesartan status
by: V. V. Fomin
Published: (2013-12-01)

Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka
by: I E Chazova, et al.
Published: (2006-03-01)

Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey
by: N M Chikhladze, et al.
Published: (2004-03-01)

The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol.
by: Anna Grigor'evna Evdokimova, et al.
Published: (2009-12-01)

Mesto agonistov imidazolinovykh retseptorov v lechenii arterial'noy gipertenzii: rezul'taty issledovaniya MERSY v Rossii
by: Irina Evgen'evna Chazova, et al.
Published: (2009-09-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK
by: Z M. Sizova
Published: (2015-09-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta
by: Ol'ga Dmitrievna Ostroumova, et al.
Published: (2013-09-01)

Novoe pokolenie blokatorov retseptorov angiotenzina
by: Valeriy Ivanovich Podzolkov, et al.
Published: (2013-09-01)

Choosing antihypertensive drug for the treatment of hypertension
by: O. D. Ostroumova, et al.
Published: (2013-12-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Effekt belogo khalata u bol'nykh stabil'noy arterial'noy gipertenziey: psikhologicheskie prediktory, dinamika na fone dlitel'noy antigipertenzivnoy terapii
by: Galiya Fatikhovna Andreeva, et al.
Published: (2013-09-01)

Kardioi nefroprotektivnye effekty agonista imidazolinovykh retseptorov moksonidina v lechenii arterial'noy gipertenzii u bol'nykh sakharnym diabetom 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2004-12-01)

Current approach to antihypertensive therapy
by: M. V. Kuznetsova
Published: (2015-12-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Vliyanie terapii bisoprololom na perfuziyu golovnogo mozga u bol'nykh s metabolicheskim sindromom
by: V B Mychka, et al.
Published: (2006-03-01)

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure
by: A K Starodubtsev, et al.
Published: (2010-12-01)

RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Kal'tsievye blokatory v profilaktike insul'ta
by: O M Drapkina
Published: (2005-06-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Conservative drug therapy for drug-resistant hypertension: time for compromise
by: A. O. Konradi
Published: (2013-12-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Комбинированная терапия артериальной гипертензии
by: Editorial Article
Published: (2014-12-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
by: O. D. Ostroumova, et al.
Published: (2016-12-01)

SEX CHARACTERISTICS OF THE MICROCIRCULATION IN HEALTHY SUBJECTS AND IN PATIENTS WITH THE FIRST DEGREE ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Terapiya irbesartanom bol'nykh sakharnym diabetom tipa 2: metabolicheskie effekty i vliyanie na perfuziyu golovnogo mozga
by: K M Mamyrbaeva, et al.
Published: (2006-06-01)

EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE
by: N. J. Borovkova, et al.
Published: (2016-01-01)

Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny
by: M V Shestakova
Published: (2006-03-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART I. CLINICAL, DIAGNOSTIC AND PATHOGENETIC ASPECTS
by: E. A. Praskurnichy, et al.
Published: (2015-09-01)

Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii
by: Aleksandr Mikhaylovich Shilov
Published: (2013-09-01)

ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART II. POSSIBILITIES OF OPTIMIZING OF ANTIHYPERTENSIVE TREATMENT
by: E. A. Praskurnichy, et al.
Published: (2015-09-01)

Antigipertenzivnaya effektivnost' valsartana, vliyanie na sostoyanie tsentral'noy gemodinamiki i mikrotsirkulyatsii: vzglyad s pozitsiy organoprotektsii
by: V I Podzolkov, et al.
Published: (2004-03-01)

GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Renal denervation to improve catheter ablation outcomes in patients with arterial hypertension and atrial fibrillation
by: Д. А. Заманов, et al.
Published: (2016-01-01)

PHARMACOEPIDEMIOLOGY AND THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT IN REAL-LIFE PRACTICE OF THE CARDIOLOGY REFERRAL CLINIC
by: A. V. Kontsevaya, et al.
Published: (2015-09-01)